The global fluoroscopy devices market Growth Accelerated by Innovations in Imaging Technologies
The fluoroscopy devices market consists of medical imaging devices that utilize fluoroscopy to generate real-time moving images of internal tissues, organs, bones, and blood vessels. Fluoroscopy devices offer non-invasive visualization of internal structures and dynamic movement without surgery, pain or incision. These imaging devices are beneficial for cardiologists, orthopedic and vascular surgeons in performing minimally invasive procedures with high precision.
The
global fluoroscopy devices market is estimated to be valued at US$ 4720.31 Mn
in 2023 and is expected to exhibit a CAGR
of 4.2% over the forecast period 2023 to 2030, as highlighted in a new
report published by Coherent Market Insights.
Market key trends:
Innovations in imaging technologies is one of the key trends fueling the growth
of the fluoroscopy devices market. With the technological advancements,
fluoroscopy devices now offer better imaging quality, high resolution,
decreased radiation dose during the procedures and simplified workflow. For
instance, the new generation of fluoroscopy devices integrate digital imaging
with advanced flat panel detectors that provide real-time imaging with high
resolution and sensitivity. They are also equipped with dose management
software that help minimize radiation exposure to critical organs. Furthermore,
the miniaturization of C-arm imaging systems allowed performing
minimally-invasive surgeries with improved ergonomics and mobility. These
innovations simplify complex clinical procedures while ensuring maximum safety
of both patients and medical professionals. This has increase the adoption rate
of new fluoroscopy devices, thereby driving the market growth over the forecast
period.
Segment Analysis
The global
fluoroscopy devices market size is segmented by product type,
application and modality. Among product type, Fixed C-arms segment dominates
the market with around 50% share in 2023. Fixed C-arms segment is dominating as
these devices offer high image quality to visualize soft tissues and blood vessels
with high precision. Stationary C-arms have remained a backbone for operating
fluoroscopy units in hospitals and healthcare facilities.
Key Takeaways
The global fluoroscopy devices market is expected to witness high growth
during the forecast period. The market is projected to reach value of US$
5345.67 Mn by 2030 from US$ 4720.31 Mn in 2023, expanding at a CAGR of 2.3%.
Regional analysis related content comprises
Geographically, North America region dominates the fluoroscopy devices market,
accounting for around 40% share in 2023. This is attributed to well-established
healthcare infrastructure, high awareness levels among healthcare professionals
about advanced medical technologies and rising elderly population with chronic
conditions in the region. Asia Pacific region is expected to witness fastest
growth during forecast period owing to growing healthcare expenditure,
increasing demand for minimally invasive surgeries and expanding medical
tourism industry in countries like India and China.
Key players related content comprises
Key players operating in the fluoroscopy devices market are Bayer AG, Henkel AG
& Co. KgaA, Avon Products Inc., Johnson & Johnson Inc., Kao
Corporation, Beiersdorf AG, Groupe Clarins SA, Revlon Inc., Shiseido Co. Ltd.,
Unilever PLC, Procter & Gamble, Lotus Herbals Pvt. Ltd. Bayer AG and
Johnson & Johnson Inc. capture around 35-40% of market share owing to their
diverse product portfolio and strong global presence.
Get
more insights on this topic: https://www.newsstatix.com/fluoroscopy-devices-market-share-and-opportunity-analysis-2023-2030/
Comments
Post a Comment